A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This is an open-label pilot study to evaluate the safety, tolerability, and efficacy of
IDN-6556 in treating portal hypertension in subjects with liver cirrhosis.